Status:

COMPLETED

MRI in Predicting Early Response to Chemotherapy in Patients With Locally Advanced Breast Cancer

Lead Sponsor:

Cancer Clinical Trials Unit, Scotland

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Phase:

PHASE2

Brief Summary

RATIONALE: Diagnostic procedures such as MRI scans may help predict early response to treatment in patients with breast cancer undergoing chemotherapy. PURPOSE: This phase II trial is studying MRI in...

Detailed Description

OBJECTIVES: * To determine the technical feasibility of using MRI in a multicenter setting using the most commonly available magnetic resonance (MR) systems (i.e., is the trial able to scan patients ...

Eligibility Criteria

Inclusion

  • DISEASE CHARACTERISTICS:
  • Newly diagnosed, histologically proven breast cancer
  • Stage T2-4B, N0-3C, and M0 disease
  • Locally advanced primary disease
  • Underwent both x-ray mammography and breast ultrasound scanning during the current treatment episode
  • Scheduled for neoadjuvant chemotherapy
  • PATIENT CHARACTERISTICS:
  • Not pregnant or nursing
  • Medically stable
  • No renal failure
  • No serious breast trauma within the past 3 months
  • No known allergic reaction associated with previous administration of a paramagnetic contrast agent
  • No known contraindication to magnetic resonance (MR) scanning
  • Must pass the normal safety requirements of MR, particularly pacemakers and cardiac defibrillators
  • No disability preventing MR scanning in the prone position
  • No body habitus incompatible with MR system entry
  • PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior chemotherapy
  • No prior surgery or radiotherapy for cancer in the ipsilateral breast
  • More than 4 months since prior surgery to the ipsilateral breast for benign breast disease

Exclusion

    Key Trial Info

    Start Date :

    August 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2010

    Estimated Enrollment :

    50 Patients enrolled

    Trial Details

    Trial ID

    NCT00978770

    Start Date

    August 1 2009

    End Date

    January 1 2010

    Last Update

    August 7 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Cactus Clinical Trials Unit

    Hull, England, United Kingdom, HU3 2KZ